Search Results - "Keserű, György M"

Refine Results
  1. 1

    GPCRdb in 2021: integrating GPCR sequence, structure and function by Kooistra, Albert J, Mordalski, Stefan, Pándy-Szekeres, Gáspár, Esguerra, Mauricio, Mamyrbekov, Alibek, Munk, Christian, Keserű, György M, Gloriam, David E

    Published in Nucleic acids research (08-01-2021)
    “…Abstract G protein-coupled receptors (GPCRs) form both the largest family of membrane proteins and drug targets, mediating the action of one-third of…”
    Get full text
    Journal Article
  2. 2

    Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia by Keserű, György M, Erlanson, Daniel A, Ferenczy, György G, Hann, Michael M, Murray, Christopher W, Pickett, Stephen D

    Published in Journal of medicinal chemistry (22-09-2016)
    “…Fragment-based drug discovery (FBDD) is well suited for discovering both drug leads and chemical probes of protein function; it can cover broad swaths of…”
    Get full text
    Journal Article
  3. 3

    Vinylation of α‑Aminoazoles with Triethylamine: A General Strategy to Construct Azolo[1,5‑a]pyrimidines with a Nonsubstituted Ethylidene Fragment by Gao, Qinghe, Sun, Zhenhua, Xia, Qinfei, Li, Ruonan, Wang, Wenlong, Ma, Siwei, Chai, Yixin, Wu, Manman, Hu, Wei, Ábrányi-Balogh, Péter, Keserű, György M, Han, Xinya

    Published in Organic letters (02-04-2021)
    “…A new general synthesis of pharmaceutically important azolo­[1,5-a]­pyrimidines starting from widely available 3(5)-aminoazoles, aldehydes, and triethylamine…”
    Get full text
    Journal Article
  4. 4

    Direct Targeting Options for STAT3 and STAT5 in Cancer by Orlova, Anna, Wagner, Christina, de Araujo, Elvin D, Bajusz, Dávid, Neubauer, Heidi A, Herling, Marco, Gunning, Patrick T, Keserű, György M, Moriggl, Richard

    Published in Cancers (03-12-2019)
    “…Signal transducer and activator of transcription (STAT)3 and STAT5 are important transcription factors that are able to mediate or even drive cancer…”
    Get full text
    Journal Article
  5. 5

    The Impact of Molecular Dynamics Sampling on the Performance of Virtual Screening against GPCRs by Tarcsay, Ákos, Paragi, Gábor, Vass, Márton, Jójárt, Balázs, Bogár, Ferenc, Keserű, György M

    “…The formation of ligand–protein complexes requires simultaneous adaptation of the binding partners. In structure based virtual screening, high throughput…”
    Get full text
    Journal Article
  6. 6

    Benchmark Sets for Binding Hot Spot Identification in Fragment-Based Ligand Discovery by Wakefield, Amanda E, Yueh, Christine, Beglov, Dmitri, Castilho, Marcelo S, Kozakov, Dima, Keserű, György M, Whitty, Adrian, Vajda, Sandor

    “…Binding hot spots are regions of proteins that, due to their potentially high contribution to the binding free energy, have high propensity to bind small…”
    Get full text
    Journal Article
  7. 7

    Site-Selective Antibody Conjugation with Dibromopyrazines by Szepesi Kovács, Dénes, Pásztor, Bettina, Ábrányi-Balogh, Péter, Petri, László, Imre, Tímea, Simon, József, Tátrai, Enikő, Várady, György, Tóvári, József, Szijj, Peter A., Keserű, György M.

    Published in Bioconjugate chemistry (18-09-2024)
    “…In recent years, antibody conjugates have evolved as state-of-the-art options for diagnostic and therapeutic applications. During site-selective antibody…”
    Get full text
    Journal Article
  8. 8

    How Are Fragments Optimized? A Retrospective Analysis of 145 Fragment Optimizations by Ferenczy, György G, Keserű, György M

    Published in Journal of medicinal chemistry (28-03-2013)
    “…Fragment optimizations in nearly 150 fragment-based drug discovery programs reported in the literature during the past fifteen years were investigated. By…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones by Mihalovits, Levente M., Kollár, Levente, Bajusz, Dávid, Knez, Damijan, Bozovičar, Krištof, Imre, Tímea, Ferenczy, György G., Gobec, Stanislav, Keserű, György M.

    Published in Chemphyschem (02-01-2024)
    “…Heterocyclic thiones have recently been identified as reversible covalent warheads, consistent with their mild electrophilic nature. Little is known so far…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Novel-Type GABAB PAMs: Structure–Activity Relationship in Light of the Protein Structure by Krámos, Balázs, Hadady, Zsuzsa, Makó, Attila, Szántó, Gábor, Felföldi, Nóra, Magdó, Ildikó, Bobok, Amrita Ágnes, Bata, Imre, Román, Viktor, Visegrády, András, Keserű, György M., Greiner, István, Éles, János

    Published in ACS medicinal chemistry letters (14-03-2024)
    “…Selecting a known HTS hit with the pyrazolo­[1,5-a]­pyrimidine core, our project was started from CMPPE, and its optimization was driven by a ligand-based…”
    Get full text
    Journal Article
  14. 14

    Activation-Free Sulfonyl Fluoride Probes for Fragment Screening by Petri, László, Ábrányi-Balogh, Péter, Csorba, Noémi, Keeley, Aaron, Simon, József, Ranđelović, Ivan, Tóvári, József, Schlosser, Gitta, Szabó, Dániel, Drahos, László, Keserű, György M

    Published in Molecules (Basel, Switzerland) (29-03-2023)
    “…SuFEx chemistry is based on the unique reactivity of the sulfonyl fluoride group with a range of nucleophiles. Accordingly, sulfonyl fluorides label multiple…”
    Get full text
    Journal Article
  15. 15

    Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors by Ábrányi-Balogh, Péter, Keeley, Aaron, Ferenczy, György G, Petri, László, Imre, Tímea, Grabrijan, Katarina, Hrast, Martina, Knez, Damijan, Ilaš, Janez, Gobec, Stanislav, Keserű, György M

    Published in Pharmaceuticals (Basel, Switzerland) (29-11-2022)
    “…Heterocyclic electrophiles as small covalent fragments showed promising inhibitory activity on the antibacterial target MurA (UDP-N-acetylglucosamine…”
    Get full text
    Journal Article
  16. 16

    Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening by Scarpino, Andrea, Bajusz, Dávid, Proj, Matic, Gobec, Martina, Sosič, Izidor, Gobec, Stanislav, Ferenczy, György G, Keserű, György M

    Published in Molecules (Basel, Switzerland) (16-07-2019)
    “…Large-scale virtual screening of boronic acid derivatives was performed to identify nonpeptidic covalent inhibitors of the β5i subunit of the immunoproteasome…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors by Szilágyi, Bence, Kovács, Péter, Ferenczy, György G., Rácz, Anita, Németh, Krisztina, Visy, Júlia, Szabó, Pál, Ilas, Janez, Balogh, György T., Monostory, Katalin, Vincze, István, Tábi, Tamás, Szökő, Éva, Keserű, György M.

    Published in Bioorganic & medicinal chemistry (01-05-2018)
    “…[Display omitted] d-Amino acid oxidase (DAAO) is a potential target in the treatment of schizophrenia as its inhibition increases brain d-serine level and thus…”
    Get full text
    Journal Article
  19. 19

    Expanding the medicinal chemistry synthetic toolbox by Boström, Jonas, Brown, Dean G., Young, Robert J., Keserü, György M.

    Published in Nature reviews. Drug discovery (01-10-2018)
    “…Analysis of the role of synthetic organic chemistry in the identification of chemical starting points for drug discovery and subsequent optimization into…”
    Get full text
    Journal Article
  20. 20

    Comparative Evaluation of Covalent Docking Tools by Scarpino, Andrea, Ferenczy, György G, Keserű, György M

    “…Increased interest in covalent drug discovery led to the development of computer programs predicting binding mode and affinity of covalent inhibitors. Here we…”
    Get full text
    Journal Article